MedicaidCoverageMedium impact
24-284m Medication Trend Updates and Formulary Changes - Second Quarter 2024
Health Net·CA · Neurology, Family Medicine, Internal Medicine +3 more·Prior Authorization
We identified it
Jun 20, 2026
Summary
Health Net updated their Medi-Cal Preferred Drug List for Q2 2024, moving three medications (Trulance, saxagliptin, and saxagliptin-metformin) to state carve-out status. Additionally, FDA issued warnings about rare but serious DRESS reactions for antiseizure medications levetiracetam and clobazam.
Action Required
Immediately: Billing team must verify current formulary status for Trulance (plecanatide), saxagliptin (Onglyza), and saxagliptin-metformin (Kombiglyze XR) in billing system for Medi-Cal patients in Imperial County. Contact Medi-Cal Rx at 800-977-2273 for coverage verification. Clinical staff should monitor patients on levetiracetam or clobazam for DRESS symptoms and document any adverse reactions.